Physician
Emergency Medicine
Dr. Jonathan A. Prince, MD
|
|
Give Review
Jonathan A. Prince, MD works in the field of Emergency Medicine. He attended Albert Einstein College of Medicine. Jonathan Prince is a published doctor and has 66 publications published. The lastest was: 'Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia.' He is registered with Medicare.
Publications
- Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.
- Sortilin receptor 1 predicts longitudinal cognitive change.
- Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease.
- Genetic Association of Sequence Variants Near AGER/NOTCH4 and Dementia.
- An assessment of CETP sequence variation in relation to cognitive decline and dementia risk.
- Serum lipid levels and cognitive change in late life.
- Sequence variation in SORL1 and dementia risk in Swedes.
- LRP-1 variation is not associated with risk of Alzheimer's disease.
- Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk.
- A survey of ABCA1 sequence variation confirms association with dementia.
- Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.
- Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci.
- Transcriptome-wide assessment of human brain and lymphocyte senescence.
- Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
- Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients.
- The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.
- Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes.
- Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract.
- Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.
- Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
- Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
- A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence.
- Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
- Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
- Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
- Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
- Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.
- Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia.
- Genes and environment behind ethnical differences in variations in left ventricular mass.
- Exercise tolerance as a predictor of acute myocardial infarction in emergency department patients with potential acute coronary syndromes.
- Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics.
- Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics.
- Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
- Towards high-throughput genotyping of SNPs by dynamic allele-specific hybridization.
- Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways.
- Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation.
- SNP association studies in Alzheimer''s disease highlight problems for complex disease analysis.
- Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer''s disease and frontotemporal dementia.
- No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer''s disease, and no change in A2M mRNA, protein, or protein expression.
- APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
- A novel screen for nuclear mitochondrial gene associations with Parkinson''s disease.
- Elevated amyloid beta protein (Abeta42) and late onset Alzheimer''s disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activ...
- Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction.
- Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer''s disease.
- apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer''s disease: finding of a positive association for a polymorphism in the TNFRSF6 gene.
- Haplotypes extending across ACE are associated with Alzheimer''s disease.
- Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer''s disease.
- Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer''s disease.
- Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction.
- A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.
- Genetic association analysis: lessons from the study of Alzheimers disease.
- Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer''s disease.
- Association of APOE with Parkinson disease age-at-onset in women.
- Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer''s disease.
- Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.
- Towards compendia of negative genetic association studies: an example for Alzheimer disease.
- Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism.
- Evidence that the gene encoding insulin degrading enzyme influences human lifespan.
- Common variants of ACE contribute to variable age-at-onset of Alzheimer''s disease.
- Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
- Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.
- Meta-analysis of the association between variants in SORL1 and Alzheimer disease.
- Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer''s disease and dementia.
- Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF amyloid-β42, and dementia.
- Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease.
Schools
Sackler School Of Medicine Tel Aviv University
Doctors Specialties
- Emergency Medicine
Accepted Insurances
Education
-
Albert Einstein College of Medicine -
Mount Sinai Beth Israel -
Tel Aviv University Sackler
Drug Facts
| NPI NUMBER | 1003830118 | |
| NPPES Provider LastName | PRINCE | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 913563501 | |
| NPPES Provider State | CA | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 134.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 14.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003830118 |
| Last Name Of The Provider | PRINCE |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
|
Dr. Terry E. Stanger, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chris Y. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina K. Rubio Holtz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saman Borghei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent W. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anthony W. Le, DPM
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory S. Brewster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph M. Baca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie S. Eng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina K. Holtz, MD |
|
|
Dr. Houtan Sabahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amnon Wein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea W. Wu, MD
This Doctor is OpenDoctor Recommended.
|